Disubstituted Sialic Acid Ligands Targeting Siglecs CD33 and CD22 Associated with Myeloid Leukaemias and B Cell Lymphomas.

导出 OA

翻译打印收藏纠错

作者： Cory D,Rillahan ^[1] ; Matthew S,Macauley ^[1] ; Erik,Schwartz ^[2] ; Yuan,He ^[1] ; Ryan,McBride ^[1] ; Britni M,Arlian ^[1] ; Janani,Rangarajan ^[1] ; Valery V,Fokin ^[2] ; James C,Paulson ^[1]

作者单位： Department of Cell and Molecular Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037 (USA) ; Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037 (USA). ^[1] Department of Chemistry, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037 (USA). ^[2]

DOI 10.1039/C4SC00451E

PMID 24921038

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Chemical science

2014年5卷6期

2398-2406页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Disubstituted Sialic Acid Ligands Targeting Siglecs CD33 and CD22 Associated with Myeloid Leukaemias and B Cell Lymphomas.

Chemical science

相似文献

Chemical science

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Disubstituted Sialic Acid Ligands Targeting Siglecs CD33 and CD22 Associated with Myeloid Leukaemias and B Cell Lymphomas.

Chemical science

相似文献

Chemical science

相关期刊

检索历史清除